IBOGF

PINK Universal Ibogaine Inc
Oct 10, 2026 · 5:20 PM ET EOD Market Closed

$0.0001 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.0001, and at the day’s high of $0.0001

YTD change
-96.97%
vs 20-day SMA
-98.92%
vs 200-day SMA
-99.44%

Price ranges

Previous day
$0.0001 $0.0001
open $0.0001 close $0.0001
+$0.0000 (+0.00%)
Today
$0.0001 $0.0001
$0.0001
Past week
$0.0001 $0.0010
from $0.0010 now $0.0001
-$0.0009 (-90.00%)
Past month
$0.0000 $0.0279
from $0.0207 now $0.0001
-$0.0206 (-99.52%)
This year
$0.0001 $0.3500
from $0.0033 now $0.0001
-$0.0032 (-96.97%)

Price & Performance

-0.01 (-99.09%) / 6M

$-0.0105$0.0404$0.0912$0.1421Apr 10Jul 8Oct 9

Signals & Sentiment

Momentum, market sentiment, and recent alerts

N/A
  • The stock is 100.0% away from all-time highs of $0.3500
  • IBOGF is down 97% since the beginning of the year
  • IBOGF is down 99% over the past 12 months
  • IBOGF is down 100% over the past 1 month
  • 0% of all IBOGF investors are betting against IBOGF

IBOGF reads n/a: price sits below both the 20- and 200-day averages, the 12-month move is -98.6%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.0001
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A
Beta 11.79

Balance sheet & scale

IncomeN/A
Revenue$1.5M
Cash$92.5K
Debt$1.9K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangePINK
Market cap $27.5K

Universal Ibogaine, Inc. engages in developing ibogaine based drug franchise to treat addiction and related mental health issues. The company was founded by Shayne Nyquvest and Alberto Solá Agulló in 2018 and is headquartered in Calgary, Canada.

Competitor comparison

No peer group available for this symbol.

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.